Correlation Between Neurobo Pharmaceuticals and Alpha Tau

Can any of the company-specific risk be diversified away by investing in both Neurobo Pharmaceuticals and Alpha Tau at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurobo Pharmaceuticals and Alpha Tau into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neurobo Pharmaceuticals and Alpha Tau Medical, you can compare the effects of market volatilities on Neurobo Pharmaceuticals and Alpha Tau and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurobo Pharmaceuticals with a short position of Alpha Tau. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurobo Pharmaceuticals and Alpha Tau.

Diversification Opportunities for Neurobo Pharmaceuticals and Alpha Tau

-0.71

Correlation Coefficient

Neurobo Pharmaceuticals  Alpha Tau

Pay attention - limited upside

The 3 months correlation between Neurobo and Alpha is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Neurobo Pharmaceuticals and Alpha Tau Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alpha Tau Medical and Neurobo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurobo Pharmaceuticals are associated (or correlated) with Alpha Tau. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alpha Tau Medical has no effect on the direction of Neurobo Pharmaceuticals i.e., Neurobo Pharmaceuticals and Alpha Tau go up and down completely randomly.

Pair Corralation between Neurobo Pharmaceuticals and Alpha Tau

Given the investment horizon of 90 days Neurobo Pharmaceuticals is expected to under-perform the Alpha Tau. In addition to that, Neurobo Pharmaceuticals is 2.05 times more volatile than Alpha Tau Medical. It trades about -0.01 of its total potential returns per unit of risk. Alpha Tau Medical is currently generating about 0.01 per unit of volatility. If you would invest  317.00  in Alpha Tau Medical on October 7, 2024 and sell it today you would lose (4.00) from holding Alpha Tau Medical or give up 1.26% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Neurobo Pharmaceuticals  vs.  Alpha Tau Medical

Neurobo Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Neurobo Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental drivers remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Alpha Tau Medical

Risk-Adjusted Performance

15 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Alpha Tau Medical are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Alpha Tau unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Neurobo Pharmaceuticals and Alpha Tau

The main advantage of trading using opposite Neurobo Pharmaceuticals and Alpha Tau positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurobo Pharmaceuticals position performs unexpectedly, Alpha Tau can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alpha Tau will offset losses from the drop in Alpha Tau's long position.

The idea behind Neurobo Pharmaceuticals and Alpha Tau Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.